TEMPUS AI INC-CL A (1TEM.MI) Fundamental Analysis & Valuation

BIT:1TEM • US88023B1035

43.04 EUR
-8.4 (-16.33%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1TEM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

1TEM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. 1TEM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1TEM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. 1TEM.MI Profitability Analysis

1.1 Basic Checks

  • 1TEM had negative earnings in the past year.
  • 1TEM had a negative operating cash flow in the past year.
  • In the past 5 years 1TEM always reported negative net income.
  • In the past 5 years 1TEM always reported negative operating cash flow.
1TEM.MI Yearly Net Income VS EBIT VS OCF VS FCF1TEM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.94%, 1TEM is doing worse than 85.71% of the companies in the same industry.
  • With a Return On Equity value of -40.15%, 1TEM is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.94%
ROE -40.15%
ROIC N/A
ROA(3y)-60.21%
ROA(5y)-54.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1TEM.MI Yearly ROA, ROE, ROIC1TEM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • With an excellent Gross Margin value of 61.73%, 1TEM belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
  • 1TEM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 1TEM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y16.28%
1TEM.MI Yearly Profit, Operating, Gross Margins1TEM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. 1TEM.MI Health Analysis

2.1 Basic Checks

  • 1TEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1TEM has less shares outstanding
  • 1TEM has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1TEM has an improved debt to assets ratio.
1TEM.MI Yearly Shares Outstanding1TEM.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
1TEM.MI Yearly Total Debt VS Total Assets1TEM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 2.32 indicates that 1TEM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.32, 1TEM perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
  • 1TEM has a Debt/Equity ratio of 2.45. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.45, 1TEM is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF N/A
Altman-Z 2.32
ROIC/WACCN/A
WACC10.72%
1TEM.MI Yearly LT Debt VS Equity VS FCF1TEM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 3.28 indicates that 1TEM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.28, 1TEM belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • A Quick Ratio of 3.12 indicates that 1TEM has no problem at all paying its short term obligations.
  • 1TEM has a better Quick ratio (3.12) than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 3.28
Quick Ratio 3.12
1TEM.MI Yearly Current Assets VS Current Liabilites1TEM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. 1TEM.MI Growth Analysis

3.1 Past

  • 1TEM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.75%, which is quite impressive.
  • Looking at the last year, 1TEM shows a very strong growth in Revenue. The Revenue has grown by 72.58%.
  • 1TEM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 62.05% yearly.
EPS 1Y (TTM)85.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56%
Revenue 1Y (TTM)72.58%
Revenue growth 3Y39.06%
Revenue growth 5Y62.05%
Sales Q2Q%84.72%

3.2 Future

  • Based on estimates for the next years, 1TEM will show a very strong growth in Earnings Per Share. The EPS will grow by 24.69% on average per year.
  • Based on estimates for the next years, 1TEM will show a very strong growth in Revenue. The Revenue will grow by 33.58% on average per year.
EPS Next Y75.55%
EPS Next 2Y35.63%
EPS Next 3Y28.86%
EPS Next 5Y24.69%
Revenue Next Year82.01%
Revenue Next 2Y50.32%
Revenue Next 3Y40.8%
Revenue Next 5Y33.58%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1TEM.MI Yearly Revenue VS Estimates1TEM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
1TEM.MI Yearly EPS VS Estimates1TEM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1TEM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1TEM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year 1TEM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1TEM.MI Price Earnings VS Forward Price Earnings1TEM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1TEM.MI Per share data1TEM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1TEM's earnings are expected to grow with 28.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.63%
EPS Next 3Y28.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1TEM.MI Dividend Analysis

5.1 Amount

  • No dividends for 1TEM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1TEM.MI Fundamentals: All Metrics, Ratios and Statistics

TEMPUS AI INC-CL A

BIT:1TEM (3/3/2026, 7:00:00 PM)

43.04

-8.4 (-16.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners51.7%
Inst Owner ChangeN/A
Ins Owners7.45%
Ins Owner ChangeN/A
Market Cap7.66B
Revenue(TTM)1.11B
Net Income(TTM)-203.88M
Analysts76.19
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.63%
Min EPS beat(2)10.18%
Max EPS beat(2)35.09%
EPS beat(4)4
Avg EPS beat(4)18.42%
Min EPS beat(4)10.18%
Max EPS beat(4)35.09%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)0.66%
Max Revenue beat(2)4.94%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-2.18%
Max Revenue beat(4)4.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)7.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.63%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.22
P/FCF N/A
P/OCF N/A
P/B 17.89
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)-1.18
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS5.24
BVpS2.41
TBVpS-1.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.94%
ROE -40.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.73%
FCFM N/A
ROA(3y)-60.21%
ROA(5y)-54.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.22%
GM growth 5Y16.28%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 2.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.04%
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.28
Quick Ratio 3.12
Altman-Z 2.32
F-Score3
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)74.55%
Cap/Depr(5y)66.22%
Cap/Sales(3y)5.14%
Cap/Sales(5y)5.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56%
EPS Next Y75.55%
EPS Next 2Y35.63%
EPS Next 3Y28.86%
EPS Next 5Y24.69%
Revenue 1Y (TTM)72.58%
Revenue growth 3Y39.06%
Revenue growth 5Y62.05%
Sales Q2Q%84.72%
Revenue Next Year82.01%
Revenue Next 2Y50.32%
Revenue Next 3Y40.8%
Revenue Next 5Y33.58%
EBIT growth 1Y65.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.29%
EBIT Next 3Y42.72%
EBIT Next 5Y35.57%
FCF growth 1Y15.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.8%
OCF growth 3YN/A
OCF growth 5YN/A

TEMPUS AI INC-CL A / 1TEM.MI FAQ

What is the fundamental rating for 1TEM stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1TEM.MI.


What is the valuation status of TEMPUS AI INC-CL A (1TEM.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to TEMPUS AI INC-CL A (1TEM.MI). This can be considered as Overvalued.


Can you provide the profitability details for TEMPUS AI INC-CL A?

TEMPUS AI INC-CL A (1TEM.MI) has a profitability rating of 1 / 10.